Early evidence of dose-dependent pharmacodynamic activity...

European Journal of Cancer 2020 / 10 Vol. 138

Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors

Papadopoulos, K., Sharma, M., Hamilton, E., Richardson, D., Bashir, B., Hodgson, G., Ke, N., Kang-Fortner, Q., Zhou, L., Zamboni, W., Jolin, H., Madigan, C., Kelly, M., Roth, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
138
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(20)31211-9
Date:
October, 2020
File:
PDF, 2.89 MB
2020
Conversion to is in progress
Conversion to is failed